Keywords: biovail, acquires, galephar, canadian, firm, acquired, puerto

Biovail acquires Galephar

Article | 25 September 1995

Print This

- Canadian firm Biovail has acquired Puerto Rico-based Galephar P R, the co-developer of Biovail's calcium channel blocker Tiazac (diltiazem).

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in